Buprenorphine Doctor in Charleston, SC
Experienced buprenorphine prescribers specializing in medication-assisted treatment for opioid use disorder.
What Is Buprenorphine?
Buprenorphine is a partial opioid agonist — it binds to the same receptors as full opioid agonists (heroin, fentanyl, oxycodone) but produces a much weaker effect at therapeutic doses. This means it reduces cravings and prevents withdrawal symptoms without producing the euphoria or dangerous respiratory depression associated with full agonists. Buprenorphine is the active ingredient in both Suboxone (combined with naloxone as a daily sublingual film/tablet) and Sublocade (monthly extended-release injection).
At Hope Addiction Medicine in West Ashley, our board-certified providers have years of combined experience managing buprenorphine for opioid use disorder. We prescribe sublingual buprenorphine films, sublingual tablets, and Sublocade injections — selecting the formulation that best fits each patient's clinical needs and lifestyle.
Why Choose a Specialist?
Since the elimination of the X-waiver requirement in January 2023, any DEA-licensed prescriber can prescribe buprenorphine for opioid use disorder. This is a positive development that has expanded access to MAT. However, prescribing authority and clinical expertise are not the same thing. Our providers specialize in MAT — they understand dose titration for different opioid use patterns, urine drug screen interpretation, managing precipitated withdrawal risk (especially with fentanyl), handling complex co-occurring conditions, and navigating court-ordered treatment requirements.
General practitioners who prescribe buprenorphine alongside their regular panel may lack the specialized experience to manage these complexities effectively. Patients across the greater Charleston area — including James Island, Johns Island, North Charleston, and Summerville — choose our West Ashley practice for this specialized expertise.
X-Waiver History and Current Requirements
Prior to 2023, prescribers needed a special DEA X-waiver to prescribe buprenorphine. This requirement limited the number of available MAT providers. The Consolidated Appropriations Act of 2023 eliminated the waiver requirement, allowing all DEA-licensed prescribers to prescribe buprenorphine. Our providers held X-waivers before the requirement was eliminated and have been prescribing buprenorphine throughout their careers — their experience predates and exceeds the minimum regulatory requirements.
Common Symptoms
Treatment Options
Frequently Asked Questions
No. As of January 2023, the X-waiver requirement has been eliminated. Any DEA-licensed prescriber can prescribe buprenorphine. However, specialized MAT experience still matters for quality of care.
Buprenorphine is the active medication. Suboxone is a brand name for buprenorphine combined with naloxone (an abuse-deterrent). Sublocade is another buprenorphine formulation delivered as a monthly injection.
Yes, any DEA-licensed prescriber can. However, if your PCP is not experienced with MAT, you may benefit from a specialist who manages opioid use disorder patients daily.
Treatment duration is individualized. Many patients remain on maintenance for a year or more. Research supports longer treatment duration for better outcomes.